"Semiconductor stocks in India" is currently one of the more misleading category names in the market — most lists under that heading don't include a single company fabricating an actual chip. Before screening anything in this space, it's worth understanding what you're actually buying exposure to.
India doesn't yet have commercial-scale chip fabrication — its first fabs are still under construction. Most "semiconductor stocks in India" today are assembly/testing (OSAT), electronics manufacturing, materials, or equipment suppliers adjacent to the industry, not chipmakers themselves. Screening this sector starts with figuring out which category a company actually falls into, since the risk profiles are very different.
The India Semiconductor Mission has committed significant capital toward building fabrication, assembly, and testing capacity domestically, and several projects are under construction. But fabrication — the part most people picture when they hear "semiconductor stock" — takes years to go from groundbreaking to commercial output. The near-term investable opportunity is concentrated in assembly, testing and packaging (ATMP/OSAT), and in the broader supply chain of materials, equipment and electronics manufacturing that supports the eventual fab ecosystem.
| Category | What it actually means |
|---|---|
| Fabrication (fabs) | Actual chip manufacturing — largely still under construction in India, not yet generating commercial revenue |
| Assembly, testing & packaging (OSAT) | Takes finished chips and packages/tests them — the nearest-term real opportunity |
| Materials & equipment suppliers | Specialty chemicals, gases, and capital equipment feeding into fab construction and operation |
| Electronics manufacturing services (EMS) | Broader contract manufacturers with growing but often minority semiconductor-related revenue |
| Design & IP services | Chip design and engineering services firms, exposed to global semiconductor demand rather than India's domestic build-out specifically |
A company can be legitimately "in" the sector while having a completely different revenue timeline, capital intensity, and execution risk than another company carrying the same label — which is exactly why treating "semiconductor stocks" as one basket is a mistake.
These questions sit on top of the same base stock screening framework — growth, ROE, debt, valuation — that applies to any sector; a hot theme doesn't exempt a stock from the fundamentals.
Our AI Watchlist flags sector rotation and momentum daily, including thematic buildouts like this one, without assuming a label alone makes a stock a buy. Bazaar AI can help you check exactly how much of a specific company's revenue is genuinely tied to semiconductors versus its legacy business.
Not yet at commercial scale — India's first semiconductor fabs are under construction as part of the government's India Semiconductor Mission, with production expected later this decade. Most "semiconductor stocks in India" today are companies adjacent to the industry: assembly and testing (OSAT), display and component manufacturing, and equipment or materials suppliers, not chip fabrication itself.
The category currently includes companies building assembly, testing, packaging (ATMP/OSAT) capacity, electronics manufacturing services companies with semiconductor-adjacent contracts, materials and specialty chemicals suppliers to the industry, and design/IP services firms. True wafer fabrication capacity is still being built.
The policy push and capital commitments are real, but stock prices in a hyped, early-stage sector often move faster than the underlying execution. Announced projects can face delays; not every company branded as a "semiconductor play" will end up meaningfully exposed to the theme by the time capacity actually comes online.
First confirm what the company actually does — fabrication, assembly/testing, equipment, materials, or just tangential exposure — since these carry very different risk profiles. Then apply standard screening: order book visibility, execution track record on large capital projects, balance sheet strength to fund capex, and valuation relative to how speculative the current revenue base still is.
Industry timelines generally point to meaningful fabrication output later in the decade, with assembly and testing capacity coming online sooner. Investors treating this as a multi-year thematic build rather than a near-term catalyst are working with a more realistic timeline than headlines often suggest.
If you found this useful, you'll like the newsletter. Each week at MultibaggerLab I share:
It's free to join and takes less than 30 seconds. Subscribe on the homepage →
Disclaimer: Nothing here is investment advice or a stock recommendation. This is educational content only.